Recent advances in solid oxide cell technology for electrolysis von Hauch, A., Kungas, R., Blennow, P., Hansen, A. B., Hansen, J. B., Mathiesen, B. V., Mogensen, M. B.

Volltext

Recurrence and mortality after first venous thromboembolism in a large population‐based cohort von Arshad, N., Bjøri, E., Hindberg, K., Isaksen, T., Hansen, J.‐B., Brækkan, S. K.

Volltext

Discovery of novel plasma biomarkers for future incident venous thromboembolism by untargeted synchronous precursor selection mass spectrometry proteomics von Jensen, S. B., Hindberg, K., Solomon, T., Smith, E. N., Lapek, J. D., Gonzalez, D. J., Latysheva, N., Frazer, K. A., Brækkan, S. K., Hansen, J.‐B.

Volltext

A modified clot-based assay to measure negatively charged procoagulant phospholipids von Ramberg, Cathrine, Jamaly, S., Latysheva, N., Wilsgård, L., Sovershaev, T., Snir, O., Hansen, J.-B.

Volltext

Cigarette smoking and the risk of venous thromboembolism: The Tromsø Study von ENGA, K. F., BRÆKKAN, S. K., HANSEN‐KRONE, I. J., le CESSIE, S., ROSENDAAL, F. R., HANSEN, J.‐B.

Volltext

C‐reactive protein, obesity, and the risk of arterial and venous thrombosis von Horvei, L. D., Grimnes, G., Hindberg, K., Mathiesen, E. B., Njølstad, I., Wilsgaard, T., Brox, J., Brækkan, S. K., Hansen, J.‐B.

Volltext

Reversible solid-oxide cells for clean and sustainable energy von Mogensen, M B, Chen, M, Frandsen, H L, Graves, C, Hansen, J B, Hansen, K V, Hauch, A, Jacobsen, T, Jensen, S H, Skafte, T L, Sun, X

Volltext

Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study von Enga, K. F., Rye‐Holmboe, I., Hald, E. M., Løchen, M.‐L., Mathiesen, E. B., Njølstad, I., Wilsgaard, T., Braekkan, S. K., Hansen, J.‐B.

Volltext

The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort von Gade, I. L., Brækkan, S. K., Næss, I. A., Hansen, J.‐B., Cannegieter, S. C., Overvad, K., Jensvoll, H., Hammerstrøm, J., Blix, K., Tjønneland, A., Kristensen, S. R., Severinsen, M. T.

Volltext

Substantial recurrence risk after venous thromboembolism provoked by minor risk factors von Brækkan, S. K., Hansen, J.‐B.

Volltext

Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study von Rinde, L. B., Lind, C., Småbrekke, B., Njølstad, I., Mathiesen, E. B., Wilsgaard, T., Løchen, M.‐L., Hald, E. M., Vik, A., Brækkan, S. K., Hansen, J.‐B.

Volltext

Repeated assessments of physical activity and risk of incident venous thromboembolism von Evensen, L. H., Isaksen, T., Hindberg, K., Brækkan, S. K., Hansen, J.‐B.

Volltext

D‐dimer at venous thrombosis diagnosis is associated with risk of recurrence von Bjøri, E., Johnsen, H. S., Hansen, J.‐B., Brækkan, S. K.

Volltext

Impact of time since diagnosis and mortality rate on cancer‐associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort von Blix, K., Gran, O. V., Severinsen, M. T., Cannegieter, S. C., Jensvoll, H., Overvad, K., Hammerstrøm, J., Tjønneland, A., Næss, I. A., Brækkan, S. K., Rosendaal, F. R., Kristensen, S. R., Hansen, J.‐B.

Volltext

Elevated plasma levels of P‐selectin glycoprotein ligand‐1‐positive microvesicles in patients with unprovoked venous thromboembolism von Jamaly, S., Basavaraj, M. G., Starikova, I., Olsen, R., Brækkan, S. K., Hansen, J.‐B.

Volltext

Venous thromboembolism and subsequent permanent work‐related disability von Brækkan, S. K., Grosse, S. D., Okoroh, E. M., Tsai, J., Cannegieter, S. C., Næss, I. A., Krokstad, S., Hansen, J.‐B., Skjeldestad, F. E.

Volltext

The loss of Sirt1 in mouse pancreatic beta cells impairs insulin secretion by disrupting glucose sensing von Luu, L., Dai, F. F., Prentice, K. J., Huang, X., Hardy, A. B., Hansen, J. B., Liu, Y., Joseph, J. W., Wheeler, M. B.

Volltext

Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study von Horvei, L. D., Brækkan, S. K., Smith, E. N., Solomon, T., Hindberg, K., Frazer, K. A., Rosendaal, F. R., Hansen, J.‐B.

Volltext

Iron: the hard player in diabetes pathophysiology von Hansen, J. B., Moen, I. W., Mandrup-Poulsen, T.

Volltext

Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø Study von VIK, A., MATHIESEN, E. B., BROX, J., WILSGAARD, T., NJØLSTAD, I., JØRGENSEN, L., HANSEN, J.‐B.

Volltext